301 related articles for article (PubMed ID: 2422317)
1. Protection of mice from lethal influenza: evidence that defective interfering virus modulates the immune response and not virus multiplication.
Dimmock NJ; Beck S; McLain L
J Gen Virol; 1986 May; 67 ( Pt 5)():839-50. PubMed ID: 2422317
[TBL] [Abstract][Full Text] [Related]
2. Protection of mice from lethal influenza by adoptive transfer of non-neutralizing haemagglutination-inhibiting IgG obtained from the lungs of infected animals treated with defective interfering virus.
McLain L; Dimmock NJ
J Gen Virol; 1989 Oct; 70 ( Pt 10)():2615-24. PubMed ID: 2794973
[TBL] [Abstract][Full Text] [Related]
3. Heterologous protection of mice from a lethal human H1N1 influenza A virus infection by H3N8 equine defective interfering virus: comparison of defective RNA sequences isolated from the DI inoculum and mouse lung.
Duhaut SD; Dimmock NJ
Virology; 1998 Sep; 248(2):241-53. PubMed ID: 9721233
[TBL] [Abstract][Full Text] [Related]
4. Protection of mice from lethal influenza by defective interfering virus: T cell responses.
McLain L; Morgan DJ; Dimmock NJ
J Gen Virol; 1992 Feb; 73 ( Pt 2)():375-81. PubMed ID: 1371542
[TBL] [Abstract][Full Text] [Related]
5. Protection of three strains of mice against lethal influenza in vivo by defective interfering virus.
Morgan DJ; McLain L; Dimmock NJ
Virus Res; 1993 Aug; 29(2):179-83. PubMed ID: 8212859
[TBL] [Abstract][Full Text] [Related]
6. Characterization of putative defective interfering (DI) A/WSN RNAs isolated from the lungs of mice protected from an otherwise lethal respiratory infection with influenza virus A/WSN (H1N1): a subset of the inoculum DI RNAs.
Noble S; Dimmock NJ
Virology; 1995 Jun; 210(1):9-19. PubMed ID: 7793084
[TBL] [Abstract][Full Text] [Related]
7. Defective interfering type A equine influenza virus (H3N8) protects mice from morbidity and mortality caused by homologous and heterologous subtypes of influenza A virus.
Noble S; Dimmock NJ
J Gen Virol; 1994 Dec; 75 ( Pt 12)():3485-91. PubMed ID: 7996140
[TBL] [Abstract][Full Text] [Related]
8. Defective interfering influenza virus inhibits immunopathological effects of infectious virus in the mouse.
Morgan DJ; Dimmock NJ
J Virol; 1992 Feb; 66(2):1188-92. PubMed ID: 1731097
[TBL] [Abstract][Full Text] [Related]
9. Protection of mice infected with a lethal dose of Semliki Forest virus by defective interfering virus: modulation of virus multiplication.
Barrett AD; Guest AR; Mackenzie A; Dimmock NJ
J Gen Virol; 1984 Nov; 65 ( Pt 11)():1909-20. PubMed ID: 6094709
[TBL] [Abstract][Full Text] [Related]
10. Defective interfering influenza virus confers only short-lived protection against influenza virus disease: evidence for a role for adaptive immunity in DI virus-mediated protection in vivo.
Scott PD; Meng B; Marriott AC; Easton AJ; Dimmock NJ
Vaccine; 2011 Sep; 29(38):6584-91. PubMed ID: 21762748
[TBL] [Abstract][Full Text] [Related]
11. Maternal-infant transfer of influenza-specific immunity not detectable by haemagglutination inhibition.
Reuman PD; Kris RM; Ayoub EM; Small PA
Microbios; 1988; 54(220-221):135-47. PubMed ID: 2846987
[TBL] [Abstract][Full Text] [Related]
12. Interfering vaccine: a novel antiviral that converts a potentially virulent infection into one that is subclinical and immunizing.
Noble S; McLain L; Dimmock NJ
Vaccine; 2004 Aug; 22(23-24):3018-25. PubMed ID: 15297051
[TBL] [Abstract][Full Text] [Related]
13. An influenza haemagglutinin-specific IgG enhances class I MHC-restricted CTL killing in vitro.
McLain L; Dimmock NJ
Immunology; 1991 May; 73(1):12-8. PubMed ID: 1646161
[TBL] [Abstract][Full Text] [Related]
14. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
[TBL] [Abstract][Full Text] [Related]
15. Cloned defective interfering influenza virus protects ferrets from pandemic 2009 influenza A virus and allows protective immunity to be established.
Dimmock NJ; Dove BK; Scott PD; Meng B; Taylor I; Cheung L; Hallis B; Marriott AC; Carroll MW; Easton AJ
PLoS One; 2012; 7(12):e49394. PubMed ID: 23251341
[TBL] [Abstract][Full Text] [Related]
16. Defective interfering virus protects elderly mice from influenza.
Scott PD; Meng B; Marriott AC; Easton AJ; Dimmock NJ
Virol J; 2011 May; 8():212. PubMed ID: 21549019
[TBL] [Abstract][Full Text] [Related]
17. Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity.
Liew FY; Russell SM; Appleyard G; Brand CM; Beale J
Eur J Immunol; 1984 Apr; 14(4):350-6. PubMed ID: 6609824
[TBL] [Abstract][Full Text] [Related]
18. Neutralization escape mutants of type A influenza virus are readily selected by antisera from mice immunized with whole virus: a possible mechanism for antigenic drift.
Lambkin R; McLain L; Jones SE; Aldridge SL; Dimmock NJ
J Gen Virol; 1994 Dec; 75 ( Pt 12)():3493-502. PubMed ID: 7527838
[TBL] [Abstract][Full Text] [Related]
19. A cell culture-derived whole-virus H9N2 vaccine induces high titer antibodies against hemagglutinin and neuraminidase and protects mice from severe lung pathology and weight loss after challenge with a highly virulent H9N2 isolate.
Wodal W; Falkner FG; Kerschbaum A; Gaiswinkler C; Fritz R; Kiermayr S; Portsmouth D; Savidis-Dacho H; Coulibaly S; Piskernik C; Hohenadl C; Howard MK; Kistner O; Barrett PN; Kreil TR
Vaccine; 2012 Jun; 30(31):4625-31. PubMed ID: 22580355
[TBL] [Abstract][Full Text] [Related]
20. Assessment of resistance to influenza virus infection in animal models.
Potter CW; McLaren C; Jennings R
Dev Biol Stand; 1975; 28():307-18. PubMed ID: 1126574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
